ArticleBioengineering (Basel, Switzerland)2025
Paper-Based Device for the Colorimetric Determination of Glucose in Whole-Blood Samples Using a Smartphone.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In many clinical settings, there is a great need for rapid, simple, and reliable diagnostic tools for the detection and quantification of various biomarkers. These tools enable early medical decisions, which can significantly influence patient recovery. Paper-based analytical devices (PADs) have become promising platforms for rapid and low-cost diagnostic testing in recent years. Among the most important biomarkers is glucose, a key metabolite involved in numerous physiological processes, which allows for the diagnosis and control of diabetes, the prevention of serious long-term complications such as cardiovascular disease, and the monitoring of the effect of medication, diet, and exercise on sugar levels in these patients. A fundamental step in detecting this marker in laboratories is the separation of plasma from whole blood. Several studies have demonstrated the successful integration of plasma separation in μPADs. This work presents the development of a paper-based device for the colorimetric detection of glucose in whole-blood samples, allowing plasma separation and using a smartphone to perform quantitative determination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.